Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron variant, the FDA said.
FDA Rescinds Authorization For Covid Antibody Treatments By Regeneron, Eli Lilly
Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron variant, the FDA said.